RN7SL326P

Across TCGA pan-cancer cohorts, RN7SL326P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RN7SL326P’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where RN7SL326P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL326P is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

PAAD and LUSC are the cancer types where RN7SL326P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL326P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Female	All	−0.415	.007	2	view →
LUSC	All	II,III,IV	+0.069	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RN7SL326P–PAAD

Open the PAAD breakdown →